Skip to main content
    O

    Orchestra BioMed Holdings Inc. (OBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.12
    -0.13 (-1.79%)

    Market Cap: $570.61M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Orchestra BioMed Holdings Inc. (OBIO) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Orchestra BioMed Holdings (OBIO) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Orchestra BioMed Holdings reported EPS of -$0.30, above the -$0.40 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    69%(11/16)
    Avg Surprise
    +18.16%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.39
    Range-$0.40 - -$0.35
    9 analysts
    Revenue Consensus
    $112.20K
    Range$88.20K - $168.00K
    9 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.37
    Range-$0.42 - -$0.32
    3 analysts
    EPS Revisions
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.36-5.2%
    60d ago-$0.370.0%
    30d ago-$0.370.0%
    7d ago-$0.370.0%
    Current-$0.37
    Revenue Consensus
    $102.20K
    Range$90.00K - $121.00K
    5 analysts

    Next Report

    OBIO has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 16 quarters below that had an estimate, OBIO beat 11, missed 4 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $91000, down 89.4% from $861000 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.30-$0.40-$0.45 - -$0.37+25.00%BeatN/A61 up, 2 downNov 10, 2026$91000
    Jun 30, 2026-$0.38-$0.35-$0.41 - -$0.28-8.57%MissN/A54 up, 1 downAug 10, 2026$88000
    Mar 31, 2026-$0.33-$0.44-$0.49 - -$0.39+25.55%BeatN/A61 up, 2 downMay 12, 2026$110000
    Dec 31, 2025$0.26-$0.38-$0.42 - -$0.34+168.42%BeatN/A71 up, 1 downMar 12, 2026$30.92M
    Sep 30, 2025-$0.40-$0.43-$0.56 - -$0.35+6.98%BeatN/A53 up, 0 downNov 10, 2025$861000
    Jun 30, 2025-$0.50-$0.51-$0.53 - -$0.49+1.96%BeatN/A60 up, 2 downAug 12, 2025$836000
    Mar 31, 2025-$0.49-$0.48-$0.61 - -$0.40-2.08%MissN/A62 up, 0 downApr 2, 2025$868000
    Dec 31, 2024-$0.42-$0.45N/A+6.67%BeatN/A63 up, 0 downMar 26, 2025$253000
    Sep 30, 2024-$0.41-$0.44-$0.45 - -$0.40+6.82%BeatN/A40 up, 0 downNov 12, 2024$987000
    Jun 30, 2024-$0.45-$0.40-$0.42 - -$0.37-12.50%MissN/A41 up, 0 downAug 12, 2024$778000
    Mar 31, 2024-$0.38-$0.38-$0.42 - -$0.380.00%In lineN/A30 up, 0 downMay 13, 2024$620000
    Dec 31, 2023-$0.37-$0.38-$0.41 - -$0.34+2.63%BeatN/A20 up, 0 downMar 27, 2024$262000
    Sep 30, 2023-$0.38-$0.39-$0.42 - -$0.36+2.56%BeatN/A20 up, 0 downNov 13, 2023$419000
    Jun 30, 2023-$0.35-$0.41N/A+14.63%BeatN/AN/AN/AAug 10, 2023$915000
    Mar 31, 2023-$0.40-$0.28N/A-42.86%MissN/AN/AN/AMay 12, 2023$1.16M
    Dec 31, 2022-$0.08-$1.71N/A+95.32%BeatN/AN/AN/AJan 24, 2023$1.10M
    Sep 30, 2022-$0.05N/AN/AN/AN/AN/AN/AN/ADec 16, 2022$1.16M
    Jun 30, 2022-$0.04N/AN/AN/AN/AN/AN/AN/AAug 15, 2022$401000
    Mar 31, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AMay 13, 2022$866000
    Dec 31, 2021$0.00N/AN/AN/AN/AN/AN/AN/AMar 31, 2022N/A
    Sep 30, 2021$0.00N/AN/AN/AN/AN/AN/AN/ANov 12, 2021N/A
    Jun 30, 2021$0.00N/AN/AN/AN/AN/AN/AN/AAug 16, 2021N/A
    Mar 31, 2021-$0.01N/AN/AN/AN/AN/AN/AN/AJun 29, 2021N/A
    Dec 31, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AMar 30, 2021N/A
    Sep 30, 2020$0.00N/AN/AN/AN/AN/AN/AN/ANov 5, 2020N/A
    Jun 30, 2020Not reportedN/AN/AN/ANot reportedN/AN/AN/AJul 17, 2020N/A
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.13, after -$1.66 the year before. It was -$0.01 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.13N/A
    Dec 31, 2024-$1.66N/A
    Dec 31, 2023-$1.50N/A
    Dec 31, 2022-$0.19N/A
    Dec 31, 2021-$0.02N/A
    Dec 31, 2020-$0.01N/A

    Frequently Asked Questions About OBIO

    When is Orchestra BioMed Holdings's next earnings date?

    Orchestra BioMed Holdings's next earnings report is expected for Mar 10, 2027.

    Did OBIO beat earnings estimates last quarter?

    Yes. Orchestra BioMed Holdings reported EPS of -$0.30 for the quarter ended Sep 30, 2026, above the -$0.40 estimate, a 25.00% surprise.

    What EPS do analysts expect from OBIO next quarter?

    The consensus EPS estimate for Orchestra BioMed Holdings for the quarter ending Dec 31, 2026 is -$0.39 from 9 analysts, with estimates from -$0.40 to -$0.35.

    How often does OBIO beat earnings estimates?

    Orchestra BioMed Holdings beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +27.99%.